# Ebrace

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ebrace

- Industry: Healthcare Specialists
- Headquarters: Guangzhou, China
- Website: www.ebrace.com.cn
- Latest round: Series B (Jul 9, 2020)
- Investors on record: 5

## About

Based in Guangzhou, China and established in 2010, Ebrace is a biotech company that focuses on the research and development of orthodontic biomaterials. In September 2023, the firm raised a strategic investment for CNY 40 million. As of 2024, the company has established cooperative relationships with more than 2,000 dental clinics and hospitals.

The company's main products include personalized lingual brackets, personalized lingual self-ligating brackets and customized braces. Its products are used in areas such as dental correction.

The company’s revenue is generated by providing personalized lingual brackets, personalized lingual self-ligating brackets and customized braces.

The company will use the strategic investment for the establishment of a digital orthodontic appliance intelligent manufacturing base in Hefei.

## Funding rounds

- Series B, Jul 9, 2020 — Korea Investment Partners, Hidea Investment
- Series B, Apr 4, 2018 — Yanghe Biomedicine Industry Investment
- Angel, Oct 19, 2012 — Leading Capital, Get Financial Holdings

## Investors

- Leading Capital — Angel
- Get Financial Holdings (https://capitalatlas.ai/funds/get-financial-holdings) — Angel
- Yanghe Biomedicine Industry Investment (https://capitalatlas.ai/funds/yanghe-biomedicine-industry-investment) — Series B
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series B
- Hidea Investment (https://capitalatlas.ai/funds/hidea-investment) — Series B